CN105998225A - Traditional Chinese medicine combination for treating rheumatiod - Google Patents
Traditional Chinese medicine combination for treating rheumatiod Download PDFInfo
- Publication number
- CN105998225A CN105998225A CN201610408319.7A CN201610408319A CN105998225A CN 105998225 A CN105998225 A CN 105998225A CN 201610408319 A CN201610408319 A CN 201610408319A CN 105998225 A CN105998225 A CN 105998225A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- radix
- traditional chinese
- rheumatiod
- medicine combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine combination for treating rheumatiod. The traditional Chinese medicine combination is prepared from raw materials including radix glycyrrhizae, semen strychni, radix clematidis, olibanum, myrrh, rhizoma atractylodis, radix bupleuri, garden balsam stems and fructus liquidambaris. The traditional Chinese medicine combination has the effects of dredging collaterals, removing stasis, clearing away heat and toxic materials and relieving swelling and pain and can improve the hepatorenal functions and the immunity of the human body so that the joints can be protected against cold invasion. For treatment on patients with rheumatiod, the traditional Chinese medicine combination is obvious in effect and high in cure rate and has no side effect, the pain of the patients is greatly relieved, and the long-term troubles of the patients with rheumatiod are solved.
Description
Technical field
The present invention relates to a kind of for treating rheumatoid Chinese medicine composition.
Background technology
Rheumatoid is a kind of common rheumatological disease, belong to liability joint disease, also it is the disease that a kind of hazardness is bigger, it is often accompanied by organ outside joint and is involved the serum rheumatoid factor (SRF) positive, may result in joint deformity and afunction, bring the most inconvenient and the biggest puzzlement to patient's daily life.In the prior art, for rheumatoid disease, doctor trained in Western medicine mainly takes Western medicine anti-inflammation, although this therapy can suppress Cycloxygenase to make front parathyrine generate suppressed and work, the effect that antiinflammatory is pain relieving can be arrived, but the process that rheumatoid arthrosis becomes can not be stoped, and therefore, it is very difficult to reach preferable therapeutic effect;And Chinese traditional treatment rheumatoid generally uses Moschus wind-damp dispelling cream, disappear the Chinese patent medicine such as pain patch, bone spur pain-eliminating capsule, and decoction for oral administration, this decoction for oral administration includes Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Radix Cyathulae, Rhizoma Sparganii, Rhizoma Curcumae, Ramulus Cinnamomi, Pheretima, Scorpio, Agkistrodon, Radix Glycyrrhizae etc.
10
Plant Chinese medicine.Although described Chinese patent medicine and
10
Plant Chinese medicine and can alleviate rheumatoid disease, but produce rheumatoid reason to be mostly because of decreased renal function and liver function is abnormal and the invasion and attack of wind-engaging cold-damp cause hyperosteogeny and other arthritis, so, want to reach preferable therapeutic effect to set about in terms of improving hepatic and renal function and body immunity, and enable joint to attack from wind and cold, now, use can heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, the Chinese medicine of reducing swelling and alleviating pain to carry out treatment be crucial.
Chinese patent 104491481A Entitled " a kind of Chinese medicine formula treating rheumatoid arthrosis change " a kind of scheme of proposition disclosed in number.This Chinese medicine formulaBagContaining oral medicine and topical agent;Described oral medicine is made up of following composition by mass: syngnathus acus Linnaeus 8-10g , Corium Erinacei Seu Hemiechianus 10-12g , Agkistrodon Fel Serpentis 1 Individual, Radix Glycyrrhizae 8-10g , old Ramulus Mori 8-10g , Fructus Liquidambaris 8-10g , Herba speranskiae tuberculatae 8-10g , Lignum Sappan 8-10g , Rhizoma Gastrodiae 10-12g ;Described topical agent is made up of following composition by mass: Scolopendra powder 12-16g , Herba speranskiae tuberculatae 10-14g , Eupolyphaga Seu Steleophaga part 10-12g , Caulis Erycibes 10-12g , discontinuously 10-12g , Herba Lycopodii 12-16g .This patent employs syngnathus acus Linnaeus, Corium Erinacei Seu Hemiechianus and Agkistrodon Fel Serpentis etc. and makes oral drug, and coordinate the medicament external application made with Scolopendra powder and Eupolyph aga sinesis Walker etc. that impaired joint is repaired, there is effect of blood circulation promoting and blood stasis dispelling, expelling wind and cold, vital base and primordial QI consolidating, alleviate and treatment rheumatoid disease, but it does not take Liver and kidney is carried out tonification, and by improve hepatic and renal function and body immunity can make joint from intrusion of pathogenic wind-cold-dampness, so, it is difficult to reach ideal therapeutic effect.
Summary of the invention
It is an object of the invention to provide and a kind of utilize the medicine improving hepatic and renal function and body immunity undesirable and have side-effect problem to treat rheumatoid Chinese medicine composition to solve therapeutic effect.
What the present invention proposed treat rheumatoid Chinese medicine composition the includes crude drug of following mass percent: Radix Glycyrrhizae
10-30%
, Semen Strychni
10-30%
, Radix Clematidis
5-20%
, Olibanum
5-15%
, Myrrha
5-20%
, Rhizoma Atractylodis
5-15%
, Radix Bupleuri
5-15%
, Herba speranskiae tuberculatae
5-15%
, Fructus Liquidambaris
5-15%
。
Wherein, Radix Glycyrrhizae is the Important Chinese Medicinal Herbs of a kind of tonification human organ, and it has effect of heat-clearing and toxic substances removing, anti-inflammation, it is possible to increase the organ dysfunctions such as Liver and kidney and immunity of human body itself, also can quickly alleviating pain;Semen Strychni has effect of activating collaterals and eliminating stagnation, reducing swelling and alleviating pain, for rheumatoid excellent curative;Radix Clematidis is the medicine of a kind of expelling wind and removing dampness, removing obstruction in the collateral to relieve pain, is particularly suitable for the symptoms such as ventilation insensitive impediment, numb limbs and tense tendons;Olibanum can be invigorated blood circulation, circulation of qi promoting, pain relieving, there is detumescence and promoting granulation effect, obstruction of qi in the chest and cardialgia, rheumatic arthralgia and traumatic injury had extraordinary curative effect;Myrrha also has dissipating blood stasis analgesic therapy, detumescence and promoting granulation effect, coordinates Olibanum to be used together the therapeutic effect promoting the diseases such as obstruction of qi in the chest and cardialgia, rheumatic arthralgia and traumatic injury;Rhizoma Atractylodis are a kind of expelling wind and removing dampness, the medicine of clots absorbing dissipating depression of QI, can dispel dampness, strengthening the spleen and stomach, cure mainly heavy sensation of the body pain, podomere is ached;Radix Bupleuri has reconciling superficies and interior, effect of soothing the liver yang invigorating, cures mainly stagnation of QI due to depression of the liver, sternal rib pain;Herba speranskiae tuberculatae promoting blood circulation and stopping pain, solution poison rash, are a kind of analgesia among the people, rheumatism, control the good medicine of traumatic injury;Fructus Liquidambaris dispels the wind diuretic, resolving mass and removing the obstruction of the collateral, and arthralgia, waist and leg ache, numb spasm, edema distension are had special effect.
The crude drug of this Chinese medicine composition also includes Radix Achyranthis Bidentatae and Semen Ricini.Wherein, Radix Achyranthis Bidentatae can restore menstrual flow and invigorate blood circulation, bone and muscle strengthening, invigorating the liver and kidney, the situation such as be particularly suitable for that lumbocrural pain, muscles and bones be unable, lower limb wither soft;Semen Ricini detumescence and drawing out poison, tranquillizing to relieve muscle spasm, expelling wind and activating blood circulation, have effect of dissipating blood stasis, pain relieving, calmness, obvious to rheumatic arthritis, traumatic injury stasis of blood pain and wind and cold effect.
In this Chinese medicine composition, the mass percent of each crude drug is: Radix Glycyrrhizae
10-30%
, Semen Strychni
10-30%
, Radix Clematidis
5-15%
, Olibanum
5-15%
, Myrrha
5-15%
, Rhizoma Atractylodis
5-15%
, Radix Bupleuri
5-15%
, Herba speranskiae tuberculatae
5-15%
, Fructus Liquidambaris
5-15%
, Radix Achyranthis Bidentatae
5-20%
, Semen Ricini
5-15%
。
The rheumatoid Chinese medicine composition for the treatment of proposed by the invention can realize the positive effect of activating collaterals and eliminating stagnation, heat-clearing and toxic substances removing, reducing swelling and alleviating pain, and the mode of oral combination external application can be used to use, thus improve hepatic and renal function and body immunity, and enable joint to attack from wind and cold, treat for rheumatoid patient, curative effect becomes apparent from and without any side effects, and cure rate height, without recurrence, alleviates a lot of misery to patient.According to statistics, the most altogether for
150
Example rheumatoid patient carries out oral and external application, Qi Zhongyou
105
Example rheumatoid patient takes Radix Glycyrrhizae, Semen Strychni, Radix Clematidis, Olibanum, Myrrha, Rhizoma Atractylodis, Radix Bupleuri, Herba speranskiae tuberculatae, Fructus Liquidambaris Chinese medicine composition, and has
45
The patient of example serious symptom with the addition of Radix Achyranthis Bidentatae and two kinds of medicines of Semen Ricini in above-mentioned Chinese medicine composition, and patient is administered orally and external application
6
After individual month, its cure rate reaches
90%
。
Detailed description of the invention
Embodiment
1
Extracting liquorice
150g
, Semen Strychni
150g
, Radix Clematidis
25g
, Olibanum
50g
, Myrrha
25g
, Rhizoma Atractylodis
25g
, Radix Bupleuri
25g
, Herba speranskiae tuberculatae
25g
, Fructus Liquidambaris
25g
.By this
9
Orally available capsule made by kind medicine or grind into powder makes Dressed plaster, is wherein administered orally every day
3
Secondary, every time
1-3
Gram;And plaster is applied at sore spot by external application, and external application in two days is once.
Embodiment
2
Extracting liquorice
50g
, Semen Strychni
50g
, Radix Clematidis
50g
, Olibanum
50g
, Myrrha
50g
, Rhizoma Atractylodis
50g
, Radix Bupleuri
50g
, Herba speranskiae tuberculatae
75g
, Fructus Liquidambaris
75g
.Oral and the external application by the mode of embodiment.
Embodiment
3
Extracting liquorice
100g
, Semen Strychni
75g
, Radix Clematidis
75g
, Olibanum
25g
, Myrrha
30g
, Rhizoma Atractylodis
75g
, Radix Bupleuri
45g
, Herba speranskiae tuberculatae
40g
, Fructus Liquidambaris
35g
.Oral and the external application by the mode of embodiment.
Embodiment
4
Extracting liquorice
50g
, Semen Strychni
150g
, Radix Clematidis
25g
, Olibanum
75g
, Myrrha
50g
, Rhizoma Atractylodis
25g
, Radix Bupleuri
50g
, Herba speranskiae tuberculatae
25g
, Fructus Liquidambaris
50g
.Oral and the external application by the mode of embodiment.
Embodiment
5
Extracting liquorice
100g
, Semen Strychni
100g
, Radix Clematidis
25g
, Olibanum
35g
, Myrrha
40g
, Rhizoma Atractylodis
30g
, Radix Bupleuri
75g
, Herba speranskiae tuberculatae
50g
, Fructus Liquidambaris
45g
.Oral and the external application by the mode of embodiment.
Embodiment
6
Extracting liquorice
150g
, Semen Strychni
100g
, Radix Clematidis
45g
, Olibanum
30g
, Myrrha
35g
, Rhizoma Atractylodis
40g
, Radix Bupleuri
30g
, Herba speranskiae tuberculatae
30g
, Fructus Liquidambaris
40g
.Oral and the external application by the mode of embodiment.
Embodiment
7
Extracting liquorice
100g
, Semen Strychni
100g
, Radix Clematidis
25g
, Olibanum
25g
, Myrrha
25g
, Rhizoma Atractylodis
25g
, Radix Bupleuri
25g
, Herba speranskiae tuberculatae
25g
, Fructus Liquidambaris
25g
, Radix Achyranthis Bidentatae
100g
, Semen Ricini
25g
.Oral and the external application by the mode of embodiment.
Embodiment
8
Extracting liquorice
150g
, Semen Strychni
50g
, Radix Clematidis
50g
, Olibanum
25g
, Myrrha
40g
, Rhizoma Atractylodis
35g
, Radix Bupleuri
25g
, Herba speranskiae tuberculatae
45g
, Fructus Liquidambaris
30g
, Radix Achyranthis Bidentatae
25g
, Semen Ricini
25g
.Oral and the external application by the mode of embodiment.
Embodiment
9
Extracting liquorice
50g
, Semen Strychni
125g
, Radix Clematidis
30g
, Olibanum
40g
, Myrrha
25g
, Rhizoma Atractylodis
35g
, Radix Bupleuri
45g
, Herba speranskiae tuberculatae
25g
, Fructus Liquidambaris
25g
, Radix Achyranthis Bidentatae
50g
, Semen Ricini
50g
.Oral and the external application by the mode of embodiment.
Embodiment
10
Extracting liquorice
75g
, Semen Strychni
75g
, Radix Clematidis
25g
, Olibanum
25g
, Myrrha
25g
, Rhizoma Atractylodis
25g
, Radix Bupleuri
25g
, Herba speranskiae tuberculatae
25g
, Fructus Liquidambaris
25g
, Radix Achyranthis Bidentatae
100g
, Semen Ricini
75g
.Oral and the external application by the mode of embodiment.
Embodiment
11
Extracting liquorice
75g
, Semen Strychni
75g
, Radix Clematidis
25g
, Olibanum
25g
, Myrrha
25g
, Rhizoma Atractylodis
25g
, Radix Bupleuri
50g
, Herba speranskiae tuberculatae
75g
, Fructus Liquidambaris
25g
, Radix Achyranthis Bidentatae
75g
, Semen Ricini
25g
.Oral and the external application by the mode of embodiment.
Claims (3)
1. treat rheumatoid Chinese medicine composition, it is characterised in that include the crude drug of following mass percent: Radix Glycyrrhizae 10-30%, Semen Strychni 10-30%, Radix Clematidis 5-20%, Olibanum 5-15%, Myrrha 5-20%, Rhizoma Atractylodis 5-15%, Radix Bupleuri 5-15%, Herba speranskiae tuberculatae 5-15%, Fructus Liquidambaris 5-15%.
Chinese medicine composition the most according to claim 1, it is characterised in that: the crude drug of this Chinese medicine composition also includes Radix Achyranthis Bidentatae and Semen Ricini.
Chinese medicine composition the most according to claim 2, it is characterized in that: in this Chinese medicine composition, the mass percent of each crude drug is: Radix Glycyrrhizae 10-30%, Semen Strychni 10-30%, Radix Clematidis 5-15%, Olibanum 5-15%, Myrrha 5-15%, Rhizoma Atractylodis 5-15%, Radix Bupleuri 5-15%, Herba speranskiae tuberculatae 5-15%, Fructus Liquidambaris 5-15%, Radix Achyranthis Bidentatae 5-20%, Semen Ricini 5-15%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610408319.7A CN105998225A (en) | 2016-06-13 | 2016-06-13 | Traditional Chinese medicine combination for treating rheumatiod |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610408319.7A CN105998225A (en) | 2016-06-13 | 2016-06-13 | Traditional Chinese medicine combination for treating rheumatiod |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105998225A true CN105998225A (en) | 2016-10-12 |
Family
ID=57090145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610408319.7A Pending CN105998225A (en) | 2016-06-13 | 2016-06-13 | Traditional Chinese medicine combination for treating rheumatiod |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105998225A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1868515A (en) * | 2005-05-27 | 2006-11-29 | 于世礼 | Traditional Chinese medicine for treating rheumatism |
CN101579487A (en) * | 2008-12-15 | 2009-11-18 | 李智军 | Capsule for treating bones and muscles |
CN101961477A (en) * | 2009-07-22 | 2011-02-02 | 靳环杰 | Rheumatic bone ache medicine |
CN102499962A (en) * | 2011-12-27 | 2012-06-20 | 尤誉环 | Traditional Chinese medicine for treating rheumatoid arthritis |
-
2016
- 2016-06-13 CN CN201610408319.7A patent/CN105998225A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1868515A (en) * | 2005-05-27 | 2006-11-29 | 于世礼 | Traditional Chinese medicine for treating rheumatism |
CN101579487A (en) * | 2008-12-15 | 2009-11-18 | 李智军 | Capsule for treating bones and muscles |
CN101961477A (en) * | 2009-07-22 | 2011-02-02 | 靳环杰 | Rheumatic bone ache medicine |
CN102499962A (en) * | 2011-12-27 | 2012-06-20 | 尤誉环 | Traditional Chinese medicine for treating rheumatoid arthritis |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101732588B (en) | Formula of Chinese medicament for treating bodily pain syndrome | |
CN104398718A (en) | Plaster for treating pains in neck, shoulder, waist and legs, and making method thereof | |
CN104288538A (en) | Plaster for treating neck, shoulder, waist and leg diseases and preparation method of plaster | |
CN106074752A (en) | A kind of external medicine composition treating osteopathia | |
CN108553633A (en) | A kind of Dressed plaster and preparation method thereof for treating rheumatism and neck-shoulder pain, lumbago and leg pain | |
CN105267389A (en) | External medicine for activating blood circulation and reducing swelling | |
CN103285202B (en) | Drug for treating rheumatism | |
CN1322885C (en) | Plaster medicine composition with multiple purpose for treating affection pain due to dampness | |
CN101019976B (en) | Hot compress medicine bag for treating osteoarthrosis | |
CN103550685A (en) | Chinese medicinal composition for treating lumbar-leg pain | |
CN102872301B (en) | Anti-rheumatism medicinal liquor and using method thereof | |
CN110755517A (en) | Pain-relieving liquid | |
CN104474494A (en) | Medicated wine for treating rheumatism | |
CN102366597A (en) | Traditional Chinese medicine preparation for prevention and treatment of nervous depression | |
CN102068647B (en) | Chinese medicinal composition for treating lumbocrural pains by ironing and warming | |
CN105998225A (en) | Traditional Chinese medicine combination for treating rheumatiod | |
CN105311520A (en) | Traditional Chinese medicine liniment for treating traumatic injuries | |
CN104758527A (en) | Traditional Chinese medicine composition for treating pain in waists and legs | |
CN100512867C (en) | Traditional Chinese medicinal preparation for treating rheumatic arthritis, rheumatoid oarthritis, intervertebral disc and ischialgia neuralgia | |
CN107375547A (en) | A kind of treat triggers the violent Chinese medicine of headache by chill | |
CN101380424A (en) | Knee-protection health-care medicinal pad | |
CN104547947A (en) | Traditional Chinese medicine composition for treating scapulohumeral periarthritis | |
CN105617214A (en) | Traditional Chinese medicine composition for treating scabies | |
CN104324190A (en) | External traditional Chinese medicine for treating mouse hand and preparation method thereof | |
CN103990017A (en) | Traditional Chinese medicine medicinal liquor for treating rheumatism |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161012 |